Decrease of the Prevalence of Helicobacter pylori Infection in the Czech Republic
Authors:
J. Bureš; M. Kopáčová; S. Rejchrt
Authors place of work:
2. interní klinika LF UK a FN, Hradec Králové
Published in the journal:
Čas. Lék. čes. 2008; 147: 255-257
Category:
Topic
Summary
Helicobacter pylori (Hp) is the most common chronic bacterial infection in humans. Hp has been demonstrated worldwide and in individuals of all ages. The overall prevalence of Hp infection has fallen dramatically in the Czech Republic over recent 15 years (from 70 % in 1993 to 35 % in 2006). This decrease can be explained mostly by the relatively favourable and improving socioeconomic conditions after the fall of communist regime. However, it is necessary to consider also the fundamental determinants of “modern times” that could cause gradual disappearing of Hp from the human “microbiome”.
Key words:
Helicobacter pylori, decrease of prevalence.
Zdroje
1. Lehours, P., Yilmaz, O.: Epidemiology of Helicobacter pylori infection. Helicobacter, 2007, 12 (Suppl. 1), s. 1–3.
2. Magalhčes Queiroz, D. M., Luzza, F.: Epidemiology of Helicobacter pylori infection. Helicobacter, 2006, 11 (Suppl. 1), s. 1–5.
3. Peura, D. A.: Bacteriology and epidemiology of Helicobacter pylori infection. UpToDate, vol. 15.3, Wellesley, 2007 (www.uptodate.com).
4. Blaser, M. J.: Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J. Infect. Dis., 2000, 179, s. 1523–1530.
5. Linz, B., Balloux, F., Moodley, Y. et al.: An African origin for the intimate association between humans and Helicobacter pylori. Nature, 2007, 445, s. 915–918.
6. Yardley, J. H., Hendrix, T. R.: Acute and chronic gastritis due to Helicobacter pylori. UpToDate, vol. 15.3, Wellesley, 2007 (www.uptodate.com).
7. Blaser, M. J.: Helicobacter pylori: balance and imbalance. Eur. J. Gastroent. Hepatol., 1998, 10 (Suppl. 1), s. S15–S18.
8. Blaser, M. J., Atherton, J. C.: Helicobacter pylori persistence: biology and disease. J. Clin. Invest., 2004, 113, s. 321–333.
9. Sedláčková, M., Souček, A., Mucksová, J.: Serologická detekce protilátek proti Helicobacter pylori u dětí a dospívajících pomocí ELISA. Českoslov. Pediatr., 1992, 47, s. 577–580.
10. Fixa, B., Komárková, O.: Prevalence of Helicobacter pylori infection in various gastroduodenal disorders. Critical view on the basis of sufficient numbers of patients. Čs. Gastroenterol., 1993, 47, s. 57–58.
11. Fixa, B., Komárková, O., Melichar, B. et al.: Výskyt infekce Helicobacter pylori u české dospělé populace. Čes. Slov. Gastroent., 1995, 49, s. 83–85.
12. Mégraud, F., Bouchard, S., Brugmann, D. et al.: Seroprevalence of Helicobacter pylori infection in six countries of eastern Europe using common methodology. Gut, 1995, 37 (Suppl. 1), s. A71.
13. Sedláčková, M., Souček, A., Dohnalová, A.: Infekce Helicobacter pylori: shlukování v rodinách. Čas. Lék. čes., 1995, 134, s. 651–654.
14. Zelenková, J., Součková, A., Souček, A. et al.: Seroprevalence Helicobacter pylori u pražské populace. Čes. Slov. Gastroent., 1998, 52, s. 51–56.
15. Dítě, P., Hep, A., Dolina, J. et al.: Prevalence infekce Helicobacter pylori v ČR– region jižní Morava. Vnitř. Lék., 1998, 44, s. 132–134.
16. Bureš, J., Dítě, P., Kopáčová, M. et al.: Prevalence of Helicobacter pylori in Czech Republic– preliminary data based on 13C–urea breath test in 389 symptom-free persons. Gut, 1999, 45 (Suppl. 5), s. A106.
17. Malaty, H., Sedláčková, M., Graham, D.Y. et al.: Helicobacter pylori infection in symptomatic and asymptomatic children in the Czech Republic. Gut, 2001, 49 (Suppl. 2), s. A80.
18. Sýkora, J., Varvařovská, J., Kuntschnerová, J. et al.: Symptomatologie a specifické rysy chronické gastritidy způsobené infekcí Helicobacter pylori v dětském věku v české populace– epidemiologicko–klinická, endoskopická a histomorfologická studie. Čas. Lék. čes., 2002, 141, s. 615–621.
19. Sedláčková, M., Malaty, H., Volf, V. et al.: Infekce Helicobacter pylori u souboru symptomatických a asymptomatických dětí a dospívajících v České republice. Čas. Lék. čes., 2003, 142, s. 102–105.
20. Bureš, J., Kopáčová, M., Koupil, I. et al.: Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter, 2006, 11, s. 56–65.
21. Bureš, J., Palička, V., Kopáčová, M. et al.: Diagnostika Helicobacter pylori pomocí dechového testu s ureou značenou přirozeným izotopem uhlíku 13C: metodika vyšetření. Čas. Lék. čes., 2000, 139, s. 776–778.
22. Kopáčová, M., Bureš, J., Voříšek, V. et al.: Clinical use of mass spectrometry in Helicobacter pylori diagnostics. Reproducibility of the 13-C-urea breath test. Clin. Chem. Lab. Med., 2001, 39, Suppl., s. 220.
23. Kopáčová, M., Bureš, J., Voříšek, V. et al.: Comparison of different protocols for (13)C–urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scand. J. Clin. Lab. Invest., 2005, 65, s. 491–498.
24. Malfertheiner, P., Megraud, F., O’Morain, C. et al.: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007, 56, s. 772–781.
25. Kopáčová, M., Bureš, J., Koupil, I. et al.: Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur. J. Epidemiol., 2007, 22, s. 67–75.
26. Kopáčová, M., Bureš, J., Koupilová, I. et al.: Prevalence of Helicobacter pylori infection in non-selected general population in Czech Republic. No birth–cohort phenomenon found in multicentre prospective study. Gut, 2002, 51, Suppl. 3, s. A108.
27. Sipponen, P.: Helicobacter pylori: a cohort phenomenon. Am. J. Surg. Pathol., 1995, 19 (Suppl. 1), s. S30–S36.
28. Šterzl, I., Hrdá, P., Matucha, P. et al.: Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol. Res., 2008, epub.
29. Jurgoš, Ľ.: Infekcia Helicobacter pylori a funkčná dyspepsia – argumenty pre a proti. Postgrad. Med. (Praha), 2003, 5, s. 530–534.
30. Oona, M., Utt, M., Nilsson, I. et al.: Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter, 2004, 9, s. 233–241.
31. Brown, L. M.: Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev., 2000, 22, s. 283–297.
32. O’Connor, H., Sebastian, S.: The burden of Helicobacter pylori infection in Europe. Aliment. Pharmacol. Ther., 2003, 18 (Suppl. 3), s. 38–44.
33. Rautelin, H., Kosunen, T. U.: Helicobacter pylori infection in Finland. Ann. Med., 2004, 36, s. 82–88.
34. Guslandi, M., Fanti, L., Testoni, P. A.: Helicobacter pylori seroprevalence in Crohn’s disease: lack of influence by pharmacological treatment. Hepatogastroenterology, 2002, 49, s. 1296–1297.
35. Pronai, L., Schandl, L., Orosz, Z. et al.: Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease– antibiotic use in the history does not play a significant role. Helicobacter, 2004, 9, s. 278–283.
36. Bateson, M. C.: Cigarette smoking and Helicobacter pylori infection. Postgrad. Med. J., 1993, 69, s. 41–44.
37. Brenner, H., Rothenbacher, D., Bode, G. et al.: Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. Br. Med. J., 1997, 315, s. 1489–1492.
38. Moayyedi, P., Forman, D., Braunholtz, D. et al.: The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am. J. Gastroent., 2000, 95, s. 1448–1455.
39. Rejchrt, S., Kopáčová, M., Koupil, I. et al.: Delta values of the 13C-urea breath test in Helicobacter pylori positive persons with and without dyspepsia. Folia Gastroenterol. Hepatol., 2004, 2, s. 105–110.
40. Rejchrt, S., Kopáčová, M., Koupil, I. et al.: Prevalence and socio–demographic determinants of uninvestigated dyspepsia in the Czech Republic. Eur. J. Gastroenterol. Hepatol., 2008 (v tisku).
Další rozsáhlá literatura je k dispozici u autorů.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Antley-Bixler syndrome or POR deficiency?
- Ten Years After the Latest Revision International Anatomical Terminology
- Effects of Mental Stress on the Health Status of the Accused during a Criminal Trial
- Medical Ethics and Ethicotherapy